These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 10414908

  • 21. Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
    Duong HK, Bolwell BJ, Rybicki L, Koo A, Hsi ED, Figueroa P, Dean R, Pohlman B, Kalaycio M, Andresen S, Sobecks R, Copelan E.
    J Clin Apher; 2011; 26(3):111-5. PubMed ID: 21647951
    [Abstract] [Full Text] [Related]

  • 22. Correlation of CD34+ cell yield in peripheral blood progenitor cell product with the pre-leukapheresis cell counts in peripheral blood.
    Sawant RB, Rajadhyaksha SB.
    J Assoc Physicians India; 2005 Dec; 53():1031-5. PubMed ID: 16572958
    [Abstract] [Full Text] [Related]

  • 23. Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients.
    Bochennek K, Andreas C, Margraf C, Stahlkamp H, Zimmermann S, Esser R, Schwabe D, Klingebiel T, Grüttner HP, Koehl U.
    Bone Marrow Transplant; 2005 Sep; 36(6):481-9. PubMed ID: 16044142
    [Abstract] [Full Text] [Related]

  • 24. Significance of low peripheral blood CD34+ cell numbers prior to leukapheresis: what should the threshold required for apheresis be?
    Gidron A, Singh V, Egan K, Mehta J.
    Bone Marrow Transplant; 2008 Oct; 42(7):439-42. PubMed ID: 18604244
    [Abstract] [Full Text] [Related]

  • 25. A single dose of 6 or 12 mg of pegfilgrastim for peripheral blood progenitor cell mobilization results in similar yields of CD34+ progenitors in patients with multiple myeloma.
    Bruns I, Steidl U, Kronenwett R, Fenk R, Graef T, Rohr UP, Neumann F, Fischer J, Scheid C, Hübel K, Haas R, Kobbe G.
    Transfusion; 2006 Feb; 46(2):180-5. PubMed ID: 16441592
    [Abstract] [Full Text] [Related]

  • 26. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation.
    Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T, Clifton R, Jovanovic B, Satkus J, Loh Y, Quigley K, Yaung K, Gonda E, Krosnjar N, Spahovic D, Burt RK.
    Bone Marrow Transplant; 2007 Mar; 39(6):317-29. PubMed ID: 17277794
    [Abstract] [Full Text] [Related]

  • 27. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
    Lefrere F, Makke J, Fermand J, Marolleau J, Dal Cortivo L, Alberti C, Mouton V, Benbunan M, Miclea J.
    Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
    [Abstract] [Full Text] [Related]

  • 28. Peripheral blood stem cell apheresis for allogeneic transplants: Ibni Sina experience.
    Arat M, Arslan O, Ayyildiz E, Topcuoglu P, Dalva K, Ilhan O.
    Transfus Apher Sci; 2004 Jun; 30(3):189-91. PubMed ID: 15172622
    [Abstract] [Full Text] [Related]

  • 29. The number of circulating CD34+ blood cells predicts the colony-forming capacity of leukapheresis products in children.
    Leibundgut K, von Rohr A, Brülhart K, Hirt A, Ischi E, Jeanneret C, Muff J, Ridolfi-Lüthy A, Wagner HP, Tobler A.
    Bone Marrow Transplant; 1995 Jan; 15(1):25-31. PubMed ID: 7538000
    [Abstract] [Full Text] [Related]

  • 30. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J, Moraleda JM, Ortuño F, Lozano ML, Ayala F, Vallejo C, de Arriba F, Vicente V.
    Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
    [Abstract] [Full Text] [Related]

  • 31. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays.
    D'Hondt L, André M, Guillaume T, Feyens AM, Humblet Y, Doyen C, Bosly A, Dromelet A, Chatelain B, Symann M.
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240
    [Abstract] [Full Text] [Related]

  • 32. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I, Cepulić BG, Mazić S.
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [Abstract] [Full Text] [Related]

  • 33. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
    Cassens U, Momkvist PH, Zuehlsdorf M, Mohr M, Kienast J, Berdel WE, Sibrowski W.
    Bone Marrow Transplant; 2001 Jul; 28(1):13-20. PubMed ID: 11498739
    [Abstract] [Full Text] [Related]

  • 34. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM, Almeida J, Lopez-Holgado N, Sanchez-Guijo FM, Alberca M, Blanco B, Sanchez-Abarca LI, Lopez O, Perez-Simon JA, San Miguel JF, del Cañizo MC.
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [Abstract] [Full Text] [Related]

  • 35. Ancestim (recombinant human stem cell factor, SCF) in association with filgrastim does not enhance chemotherapy and/or growth factor-induced peripheral blood progenitor cell (PBPC) mobilization in patients with a prior insufficient PBPC collection.
    da Silva MG, Pimentel P, Carvalhais A, Barbosa I, Machado A, Campilho F, Sousa SR, Miranda N, da Costa FL, Campos A, Vaz CP, Antas J, Passos-Coelho JL.
    Bone Marrow Transplant; 2004 Oct; 34(8):683-91. PubMed ID: 15322567
    [Abstract] [Full Text] [Related]

  • 36. Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization.
    Meehan KR, Hill JM, Patchett L, Webber SM, Wu J, Ely P, Szczepiorkowski ZM.
    Transfusion; 2006 Apr; 46(4):523-9. PubMed ID: 16584427
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
    Li B, Yang JL, Shi YK, He XH, Han XH, Zhou SY, Liu P, Yang S, Zhang CG.
    Cytotherapy; 2009 Apr; 11(3):362-71. PubMed ID: 19037766
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.